<DrugInformationSummary id="CDR0000760376"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Ramucirumab works by blocking a protein called VEGFR-2, which some cancer cells produce in large amounts. Blocking VEGFR-2 may prevent the growth of new blood vessels that tumors need to grow. Ramucirumab is a type of targeted therapy drug called an angiogenesis inhibitor.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/ramucirumab">Ramucirumab</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000570535">ramucirumab</TerminologyLink><GlossaryLink ref="CDR0000648687">ramucirumab</GlossaryLink><USBrandNames><USBrandName>Cyramza</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>RA-myoo-SIR-yoo-mab</TermPronunciation><MediaLink ref="CDR0000726213" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000726212" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c6080942-dee6-423e-b688-1272c2ae90d4&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Ramucirumab</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c6080942-dee6-423e-b688-1272c2ae90d4&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Ramucirumab
         is approved 
         to be used alone or with other drugs to treat:</Para>                          
  <ItemizedList Style="bullet" id="_3">
   
   
   <ListItem><Strong><GlossaryTermRef href="CDR0000444983" dictionary="Cancer.gov" audience="Patient">Colorectal cancer</GlossaryTermRef></Strong> that has <GlossaryTermRef href="CDR0000046283" dictionary="Cancer.gov" audience="Patient">metastasized</GlossaryTermRef>. It is used with <GlossaryTermRef href="CDR0000635808" dictionary="Cancer.gov" audience="Patient">FOLFIRI</GlossaryTermRef> in patients whose disease has gotten worse during or after treatment with <GlossaryTermRef href="CDR0000046115" dictionary="Cancer.gov" audience="Patient">bevacizumab</GlossaryTermRef>, <GlossaryTermRef href="CDR0000045465" dictionary="Cancer.gov" audience="Patient">oxaliplatin</GlossaryTermRef>, and a <GlossaryTermRef href="CDR0000386207" dictionary="Cancer.gov" audience="Patient">fluoropyrimidine</GlossaryTermRef>.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000046363" dictionary="Cancer.gov" audience="Patient">Hepatocellular carcinoma</GlossaryTermRef></Strong> (a type of <GlossaryTermRef href="CDR0000044242" dictionary="Cancer.gov" audience="Patient">liver cancer</GlossaryTermRef>). It is used alone in patients who have a high level of <GlossaryTermRef href="CDR0000046208" dictionary="Cancer.gov" audience="Patient">alpha-fetoprotein</GlossaryTermRef> in the blood and have been treated with  <GlossaryTermRef href="CDR0000509041" dictionary="Cancer.gov" audience="Patient">sorafenib tosylate</GlossaryTermRef>.</ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000045323" dictionary="Cancer.gov" audience="Patient">Non-small cell lung cancer</GlossaryTermRef></Strong> that has metastasized. It is used:<ItemizedList Style="bullet" id="_5"><ListItem>With <GlossaryTermRef href="CDR0000508929" dictionary="Cancer.gov" audience="Patient">erlotinib hydrochloride</GlossaryTermRef> as <GlossaryTermRef href="CDR0000346494" dictionary="Cancer.gov" audience="Patient">first-line therapy</GlossaryTermRef> in patients whose disease has certain <GlossaryTermRef href="CDR0000046063" dictionary="Cancer.gov" audience="Patient">mutations</GlossaryTermRef> in the <GeneName><GlossaryTermRef href="CDR0000796876" dictionary="Cancer.gov" audience="Patient">EGFR</GlossaryTermRef></GeneName> gene.</ListItem><ListItem>With <GlossaryTermRef href="CDR0000045382" dictionary="Cancer.gov" audience="Patient">docetaxel</GlossaryTermRef> in patients whose disease has gotten worse during or after treatment with <GlossaryTermRef href="CDR0000045841" dictionary="Cancer.gov" audience="Patient">platinum</GlossaryTermRef> chemotherapy. For  patients whose disease has a mutation in the <GeneName>EGFR</GeneName> gene or  <GeneName><GlossaryTermRef href="CDR0000721252" dictionary="Cancer.gov" audience="Patient">ALK</GlossaryTermRef></GeneName> gene, ramucirumab is used if their disease has gotten worse after treatment with <GlossaryTermRef href="CDR0000454786" dictionary="Cancer.gov" audience="Patient">FDA</GlossaryTermRef>-approved therapy for these mutations.</ListItem></ItemizedList> </ListItem><ListItem><Strong><GlossaryTermRef href="CDR0000445087" dictionary="Cancer.gov" audience="Patient">Stomach</GlossaryTermRef> <GlossaryTermRef href="CDR0000046216" dictionary="Cancer.gov" audience="Patient">adenocarcinoma</GlossaryTermRef></Strong> or <Strong><GlossaryTermRef href="CDR0000302458" dictionary="Cancer.gov" audience="Patient">gastroesophageal junction</GlossaryTermRef> adenocarcinoma</Strong> (a rare type of <GlossaryTermRef href="CDR0000444989" dictionary="Cancer.gov" audience="Patient">esophageal cancer</GlossaryTermRef>) that is <GlossaryTermRef href="CDR0000478743" dictionary="Cancer.gov" audience="Patient">advanced</GlossaryTermRef> or has metastasized (spread to other parts of the body). It is used in patients whose disease has gotten worse after treatment with a fluoropyrimidine or platinum chemotherapy. It is used alone or with <GlossaryTermRef href="CDR0000045258" dictionary="Cancer.gov" audience="Patient">paclitaxel</GlossaryTermRef>.</ListItem></ItemizedList>
  <Para id="_4">Ramucirumab
         is also being studied in the treatment of other types of
         cancer.</Para>
 </Section><Section id="_About"><Title>More About Ramucirumab</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/570535">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.49">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a614026.html">Ramucirumab</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.50"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.51">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/monoclonal-antibodies">Monoclonal Antibodies</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/checkpoint-inhibitors">Immune Checkpoint Inhibitors</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/angiogenesis-inhibitors-fact-sheet">Angiogenesis Inhibitors</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C70792">Find Clinical Trials for Ramucirumab</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2014-05-08</DateFirstPublished><DateLastModified>2023-12-08</DateLastModified></DrugInformationSummary>
